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Abstract
The severe dystroglycanopathy known as a form of limb-girdle muscular dystrophy
(LGMD2P) is an autosomal recessive disease caused by the point mutation T192M in α-
dystroglycan. Functional expression analysis in vitro and in vivo indicated that the mutation
was responsible for a decrease in posttranslational glycosylation of dystroglycan, eventual-
ly interfering with its extracellular-matrix receptor function and laminin binding in skeletal
muscle and brain. The X-ray crystal structure of the missense variant T190M of the murine
N-terminal domain of α-dystroglycan (50-313) has been determined, and showed an overall
topology (Ig-like domain followed by a basket-shaped domain reminiscent of the small sub-
unit ribosomal protein S6) very similar to that of the wild-type structure. The crystallographic
analysis revealed a change of the conformation assumed by the highly flexible loop encom-
passing residues 159–180. Moreover, a solvent shell reorganization around Met190 affects
the interaction between the B1–B5 anti-parallel strands forming part of the floor of the bas-
ket-shaped domain, with likely repercussions on the folding stability of the protein domain
(s) and on the overall molecular flexibility. Chemical denaturation and limited proteolysis
experiments point to a decreased stability of the T190M variant with respect to its wild-type
counterpart. This mutation may render the entire L-shaped protein architecture less
flexible. The overall reduced flexibility and stability may affect the functional properties of
α-dystroglycan via negatively influencing its binding behavior to factors needed for
dystroglycan maturation, and may lay the molecular basis of the T190M-driven primary
dystroglycanopathy.
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Introduction
Dystroglycan (DG) is composed of two subunits, α and β, that are formed from a unique pre-
cursor which undergoes a proteolytic event within the endoplasmic reticulum during the first
steps of its maturation pathway [1, 2]. DG represents a widely expressed adhesion complex
that plays a crucial role in offering stability to tissues, being at the crossroad between cytoskele-
ton, plasma membrane and the surrounding extracellular matrix [3, 4]. The DGmain role is to
bind with high-affinity laminins that are central organizers of the molecular network behind
specialized basement membranes surrounding skeletal muscle. Besides, DG may form a pletho-
ra of additional interactions with other binding partners sharing laminin globular (LG) do-
mains within epithelia, endothelia and Schwann cells. Indeed, its binding affinity may largely
vary based on the degree of glycosylation of its α subunit [5].
DG has been particularly studied within skeletal muscle, a tissue where its α-subunit is
found to be highly glycosylated, since a number of neuromuscular diseases involving glycosyl-
transferases active in muscle have been identified during the last years [6]. The commonly ac-
cepted molecular scenario implies that hypoglycosylated DG cannot bind the skeletal muscle
laminin-2 [7] with the usual high affinity, which would lead to the reduction of sarcolemma
stability at the basis of a wide number of severe, or later onset, muscular dystrophies, defined as
secondary dystroglycanopathies [6].
The α-subunit plays multiple important roles in DG, in that i) it is crucially involved in the
maturation and posttranslational modification of the precursor; ii) it is highly modified with
sugar chains especially in its central region (i.e. the mucin-like portion) from where some es-
sential sugar moieties protrude to bind laminin. The first is based on the noncovalent binding
activity of α-DG toward β -DG [8] while for the latter, it seems that the N-terminal domain
may be central in recognizing and directing the activity of important modifying enzymes, such
as the like-acetylglucosaminyltransferase LARGE, that adds the repeating disaccharide block
[-α3-glucuronic acid (GlcA)-β3-xylose (Xyl)-) required for laminin-binding [9] to a phosphor-
ylated mannose of α-DG [10].
We have pioneered studies on α-DG at the molecular level [11], having extensively charac-
terized the structure of its N-terminal domain, which is shaped in two subdomains [12]. The
first is a typical Ig-like domain, while the second one is similar to the S6 protein present in the
small ribosomal subunit of T. termophilus [13].
Although a plethora of interesting studies are currently unraveling the structure of the sugar
blocks modifying the mucin-like domain of α-DG as well as the exact residues of α-DG in-
volved in these modifications [14–17], no ultimate structural information is currently available
on the dystroglycan/laminin complex at the molecular level. The challenges in obtaining crys-
tals of the complex mainly arise from the highly heterogeneous nature of α-DG glycosylation,
confirmed by the fact that the protein can be typically visualized in overlay assays or Western
blots as a band with a broad smear appearance indicating a distribution of different molecular
masses [1, 3, 4].
Recently, Hara and colleagues have extensively analyzed the effect of a missense mutation
(T192M) causing the first primary dystroglycanopathy identified so far [18]; nevertheless, the
exact molecular mechanism behind this autosomal recessive pathology has yet to be fully clari-
fied. Interestingly, the human T192Mmutation (and its topological murine counterpart,
T190M, which causes a similar dystrophic phenotype in a mouse model [18]), lies within the
strand B1 that together with the strands B2, B3, B4 and B5, arranged in an anti-parallel topolo-
gy, defines the floor of the basket shaped S6-like domain [13]. Theoretically, the Thr to Met
semiconservative mutation is unlikely to cause per se a high degree of disorder/instability, and
it should not represent a site of O-glycosylation.
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Nonetheless, we believe that the structural analysis of the T190Mmutant of α-DG is a fun-
damental step towards the understanding at the molecular level of the mechanism leading to
muscular dystrophy. Following this basic idea, we inserted the murine mutant in our recombi-
nant system for expression in E.coli, and purified it for crystallization studies aimed at possibly
solving its structure and comparing it with that of the wild-type protein previously reported
[13].
Materials and Methods
Mutagenesis and primers
Traditionally, we have worked on murine dystroglycan since it displays a very high degree of
identity (93%) with human α-DG. We introduced an additional mutation, R166H, within the
N-terminal domain of α-DG in order to make it more resistant to proteolysis [13]; both the
wild-type and the mutated variants herein analyzed harbor this mutation. The murine α-DG
(50–313)R166H (hereinafter WT) DNA was cloned into a bacterial vector, pHis-Trx, for the
expression of the protein as thioredoxin fusion product, also containing an N-terminal 6xHis
tag and a thrombin cleavage site, as previously described [13]. The point mutation T190M was
introduced into the WT DNA construct using the QuikChange site-directed mutagenesis kit
(Stratagene) and appropriate primers. Briefly, the mutation was inserted within the coding re-
gion of the WT N-terminal domain cloned in the vector pHis-Trx [13] for prokaryotic expres-
sion aimed at crystallographic analysis, and within the entire cDNA sequence of the murine
DG cloned in the pEGFP-N1 plasmid for expression in eukaryotic cells [19], respectively, using
the following primers:
Forward: 5’-CCAGTGACTGTCCTTATGGTGATTCTGGATGCT-3’
Reverse: 5’-AGCATCCAGAATCACCATAAGGACAGTCACTGG-3’
The construct DGT190M-pEGFP-N1 allows to express DG with a Green Fluorescent Protein
(GFP) fused at the C-terminus of β-DG. Moreover, a Myc tag is present, inserted after Lys498,
within the C-terminal domain of α-DG [19]. All constructs were verified by automated
sequencing.
Fusion protein expression and purification
The recombinant α-DG(50–313)R166H T190M (hereinafter T190M) fusion protein was ex-
pressed in Escherichia coli BL21(DE3) Codon Plus RIL strain and purified using nickel affinity
chromatography. The fragment of interest was obtained upon thrombin cleavage. Further puri-
fication steps were carried out using anion exchange and gel filtration chromatography. Name-
ly, after thrombin cleavage, the flow through of a HiTrap Chelating column (GE Healthcare)
was applied onto a Hi-Trap Q HP column (GE Healthcare) pre-equilibrated with buffer A
(25 mM Tris–HCl pH 7.5). T190M was eluted with a linear gradient of 0–0.5 M NaCl in buffer
A. The fractions containing T190M were pooled, concentrated with Amicon Ultra 15 (Milli-
pore) and loaded on Superdex 200 10/300 GL (GE Healthcare) pre-equilibrated with 25 mM
Tris–HCl pH 7.5, 0.15M NaCl, at a flow rate of 0.4 mL/min: the core fractions of the peak were
supplemented with 2.5% Glycerol and concentrated by Microcon GM10 (Millipore). The puri-
ty of the protein was confirmed by Tricine/SDS-PAGE [20].
The possibility that the methyl sulfide (thioether) of Met 190 would be oxidized in T190M,
or in general that the recombinant protein would harbor some additional undesired modifica-
tions, has been ruled out via mass spectrometry analysis exploiting an Orbitrap instrument
(Thermo Scientific). The corresponding mass value obtained also confirmed the presence of a
disulfide bridge between Cys180 and Cys262.
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Crystallization, data collection, structure solution, and refinement
Crystals of T190M were grown by using the vapor diffusion hanging drop method, following
the protocol used for the crystallization of WT [13]. Drops were prepared by mixing 1 μL of
the protein solution (5.25 mg/mL in 25 mM Tris, 150 mMNaCl and 2.5% glycerol; pH 7.5)
with 1 μL of the precipitant solution (0.8 M citrate buffer; pH 7.0) and equilibrated against the
reservoir (1 mL) at 4°C.
Data collection was carried out at the European Synchrotron Radiation Facility Grenoble
(France), ID23-1 beamline, using a detector Pilatus-6M (Dectris) and the wavelength of 1.00 Å.
Data collection was carried out at -173°C. Before being exposed to the X-ray beam, crystals
were quickly dipped in cryoprotectant solution (25% ethylene glycol, 1.0 M citrate buffer, pH
7.0) and flash frozen in liquid nitrogen.
Indexing, integration and data reduction of the diffraction data were carried out by using a
combination of XDS [21] and CCP4 [22] programs. Data reduction statistics are reported in
Table 1.
The structure solution of T190M was obtained by Patterson search methods with PHASER
[23] using the crystal structure of WT as template (PDB id: 1U2C). Restrained refinement of
the crystal structure was carried out by using phenix.refine [24]. The improvement of the initial
model underwent a protocol that included a rigid body fitting stage followed by simulated an-
nealing, coordinates and individual B-factors refinement. The subsequent stages integrated a
Translation-Libration-Screw (TLS) model parameterization before the individual B-factors re-
finement. Automatic refinement cycles were alternated with manual rebuilding sessions per-
formed with COOT [25]. Solvent molecules were identified by the automatic water-picking
algorithm implemented in phenix.refine [24]. The overall quality of these automatically picked
solvent molecules were manually checked. Multiple conformations were introduced for select-
ed side chains during the last cycles of refinement.
Protein stereochemistry was monitored throughout the refinement process and during
manual rebuilding with MolProbity [26]. Statistics of the crystallographic refinement are re-
ported in Table 1.
Protein structures superposition was carried out using ProFit (Martin, A.C.R., http://www.
bioinf.org.uk/software/profit/). The STRIDE web-server was used to assign the protein second-
ary structure [27]. Interfaces between domains, solvent accessible areas and solvation energies
were analyzed by using PISA as part of the CCP4 package [28]. Waters-protein interactions
were analyzed using the WAP web-server [29].
Coordinates and structure factors have been deposited in the PDB, with accession code:
4WIQ. Figures were prepared using PyMol [30].
Fluorescence analysis
Equilibrium fluorescence titrations were performed in 50 mM Tris HCl, pH 7.4, with spectra
collected at each guanidine hydrochloride (GdnHCl) concentration (point by point, as to avoid
photo-bleaching phenomena) at 25°C in a 1-cm quartz cuvette using a fluorescence spectro-
photometer Cary Eclipse (Agilent Technologies). The final concentration of protein (both WT
and T190M) was 0.1 μM, and for each point spectra were taken after 20 minutes of equilibra-
tion time [31]. The excitation wavelength was 280 nm, and emission spectra were recorded be-
tween 300 and 400 nm. The fluorescence peak change as a function of GdnHCl concentration
was fitted as described elsewhere [31]; calculations were carried out using the Kaleidagraph
software. All the reagents used were of high purity grade from Sigma.
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Limited proteolysis
WT and T190M at 30 μM in 50 mM Tris (pH 8) buffer were subjected to limited proteolysis at
37°C by the addition of trypsin (Sigma) to a final concentration of 2 μg/mL. The reaction was
stopped after 1, 5, 10, 20, 40 and 60 min by adding SDS sample buffer to aliquots of the reaction
mixture. The samples were analyzed by performing 15% SDS-PAGE and Coomassie staining.
As a control the same time course was performed in the absence of the enzyme.
Table 1. X-ray diffraction: data collection andmodel refinement statistics.
Data Collection
Space group H 3
Unit-cell parameters (Å) a = 71.879, c = 144.296
Molecules per asymmetric unit 1
Wavelength (Å) 1.00
Resolution (Å) 48.1–1.59 (1.65–1.59)a
Total observations 119373
Unique reﬂections 35504
Rmerge (%)
b 4.3 (44.2)
<I/ σ (I)> 15.28 (1.74)
Completeness (%) 95.0 (71.8)
Redundancy 3.4 (2.3)
Reﬁnement
Number of reﬂections (work-set/test-set) 33720/ 1784
Rwork
c/ Rfree
d (%) 14.61 / 16.32
Number of non-H atoms
Protein 1741
Waters 194
Organic (ethylene glycol) 12
Ions (Cl-) 1
Average isotropic B factors (Å2) 32.9
Protein (main chain) 28.9
Protein (side chain) 35.8
Solvents 39.1
r.m.s. deviation
Bond length (Å) 0.010
Angle (deg) 1.245
Ramachandran plot
favored regions (%) 100
allowed regions (%) 0
disallowed regions (%) 0
PDB code 4WIQ
a Values in parenthesis are given for the highest resolution shell
b Rmerge = ∑hkl∑j│Ihkl, j-<Ihkl>│/ ∑hkl∑j Ihkl, j
c Rwork = ∑work-set│Fobs-Fcal│/ ∑work-set Fobs
d Rfree = ∑test-set |Fobs-Fcal|/ ∑test-set Fobs
doi:10.1371/journal.pone.0124277.t001
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Super Resolution Microscopy with 3D SIM
Human osteosarcoma U2OS cells cultured in DMEM, 10% FBS, were seeded on No. 1.5H pre-
cision cover glass (Marienfeld-Superior). The cells were transfected with the corresponding
pEGFP-N1 vectors expressing full-length DG, WT and T190M, with polyethylenimine (PEI)
precipitates based on a 3:1 ratio of PEI (μg) to total DNA (μg). 48h post transfection the cells
were fixed in 4% PFA.
Lipid staining was achieved after 30 minutes incubation in a 1:2000 dilution of Cellmask
Plasma Membrane Orange dye (Invitrogen). For the immunostaining of the Myc-tag fused to
DG, cells were permeabilized for 90 seconds in 0.5% Triton X100 and washed in PBS. Cells
were blocked in 5% BSA in PBS for 1h followed by an incubation with 1:1000 dilution of pri-
mary rabbit polyclonal anti-c-Myc antibody (C3956 from Sigma-Aldrich) in PBS 0.1% Tween-
20 for 1h at room temperature. Secondary goat anti-rabbit antibody conjugated to Alexa-
Fluor647 (A-21244, Life Technologies) was applied at a 1:400 dilution for 1h after several
washes in PBS 0.1% Tween-20. The cells were finally washed three times in PBS. The cover
glass was mounted in Vectashield containing DAPI (Vector Laboratories) for nuclear counter
stain and sealed with nail polish.
U2OS cells expressingWT-EGFP and T190M-EGFP were imaged on a 3D Structured Illumi-
nation Microscope (3D-SIM) OMX v.4 (GE Healthcare). The refraction index of the immersion
oil was chosen to avoid spherical aberrations in the green emission channel. DAPI was excited
with a 405 nm, EGFP with 488 nm, Cellmask PlasmaMembrane Orange with 568 nm and goat
anti-rabbit antibodies bound to AlexaFluor647 with 647nm laser, while sCMOS cameras re-
corded the corresponding emission in the following bandwidth of 436/31 nm, 528/48 nm, 609/
37 nm and 683/40nm. The 3D structured illumination images were reconstructed in the Soft-
worx v6.1.1 software (GE Healthcare) at a Wiener filter setting of 0.004 and using one week old
recorded OTFs optimized for the 528 nm emission channel. For presentation here, the final im-
ages were adjusted linearly in intensities with the software package Fiji [32] to minimize any visi-
ble spherical aberrations in the blue and red emission channels. Raw data are available
upon request.
Results
Crystallization and crystal structure determination
Well shaped crystals of T190M grew in 7–10 days as regular slabs that diffracted X-rays.
The crystal structure of T190M has been determined and refined up to a resolution of 1.6 Å.
The final model includes residues (58–163) and (179–303), that could be traced in the 2Fo-Fc
electron density map. The overall structure of T190M does not show global differences with re-
spect to WT. The root-mean-square deviation (RMSD) between the T190M andWT structures
is 0.758 Å (calculated on 268 Cα), which decreases to 0.297 Å when omitting from the RMSD
calculation the 4 residues (157–160) being part of the flexible loop discussed in the next para-
graph. As reported for WT [13], the structure of T190M consists of two domains (Fig 1): the
first one described as an Ig-like domain (residues 60–158) and the second one (residues 180–
303) similar to the small subunit ribosomal protein S6. The spatial organization of the domains
is conserved in the T190M crystal structure as well as the interaction surfaces between the two
domains. A flexible loop, which links together the two domains, could be traced only at the N-
terminal side (residues 159–163: His-Asn-Glu-Pro-Gln). It should be noted that the WT struc-
ture refers anyway to a protein carrying the additional single mutation R166H that was origi-
nally introduced to stabilize the recombinant protein during purification [13]. The same
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mutation is also present in T190M, although this position falls into the region of the flexible
loop that could not be traced in WT as well as in T190M (see below).
The crystallographic analysis confirmed the substitution of Thr190 with Met, as showed in
Fig 2 and, according to the refined model, the T190Mmutation does not introduce significant
Fig 1. Cartoon depiction of the T190M crystal structure. The two domains are colored in violet (Ig-like
domain) and green (small ribosomal S6 subunit domain), respectively; the B1 and B5 β-strands are labeled
for clarity. Spheres representation is employed for highlighting Met190. The loop regions connecting the two
domains are shown for both WT (colored in cyan) and T190M (colored in red). Residues Ala58 and Thr303
(N- and C-term residues) together with Gln163 and Ala179 (N- and C-term of the modeled loop in the T190M
crystallographic structure) are highlighted as stick-and-ball representation.
doi:10.1371/journal.pone.0124277.g001
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conformational changes in the structure. These findings altogether indicate that this mutation
does not significantly alter the overall fold of T190M with respect to that of WT.
Despite showing very similar crystal structures, WT and T190M differ in the conformation
of the flexible loop linking the two domains (residues 159–179). Indeed the conformation of
the residues (158–163) in T190M, that has been best modeled based on the Fourier maps (Figs
3 and 4) and by monitoring the Rfree, differs with respect to the one being observed for residues
Fig 2. Calculated σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in light-blue) and Fo-Fc map
(contoured at ± 3.0 σ and colored in green for positive values and in orange for negative values). The
maps have been calculated following the Patterson search stage using theWT as a model (PDB id: 1U2C).
The final model of T190M (colored in blue) is superposed to the initial Patterson search solution (colored in
pink-salmon). Both models are represented as ribbon except residues at position 190 (Thr for the template
structure and Met for the mutated final model), which are represented as sticks.
doi:10.1371/journal.pone.0124277.g002
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(158–160) in WT (PDB id: 1U2C). The refined structure thus suggests that the main-chain
loop conformation has changed in T190M with respect to WT. Moreover, in T190M the loop
could be traced for three additional residues, up to Gln163, with respect to the WT structure,
with residues (158–161) assuming a β-Turn structure (Figs 3 and 5). Being the WT and the
T190M crystallization conditions almost identical and the crystal structures exhibiting the
same packing features, it is reasonable to correlate the observed differences in the loop confor-
mation to the Thr vsMet mutation, which would result in a less flexible loop and in an in-
creased proximity of the loop to the side chain of the mutated residue.
Residue 190 is located at the center of the B1 β-strand, at the bottom of the basket-like do-
main and is solvent exposed [13]. The point mutation Thr to Met does not introduce drastic
Fig 3. SA-omit σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in grey) and Fo-Fc map (contoured at 3.0 σ and colored in green) overlaid
with the loop region encompassing residues (156–163) as the T190M final model (PDB id 4WIQ).Maps have been calculated using the T190Mmodel,
where residues (156–163) have been omitted from the calculation. The loop of the T190M final model nicely fits the 2Fo-Fc maps, which is indicative of the
soundness of the built model.
doi:10.1371/journal.pone.0124277.g003
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local changes in the structure. The Met residue nicely superposes on the position occupied by
Thr in the WT (Fig 2), with the Cβ-Cγ bond rotated by 20° with respect to the corresponding
bond (Cβ-Cγ2) in Thr, while the Cγ-Sδ-Cε group is pointing towards the solvent region. Also
the nearby residues geometries are not greatly affected by the point mutation.
Despite the limited effect of the Thr to Met mutation on the neighboring residues, the intro-
duction of a bulkier and apolar group such as the methylthio group of the methionine causes a re-
organization of the surrounding water molecules. An analysis made with PISA [28] shows that
the solvent exposed surface is more than doubled when considering Thr in theWT ( 13 Å2) and
Met in the T190Mmutant ( 34 Å2). Furthermore, the solvation energy contribution estimated
Fig 4. SA-omit σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in grey) and Fo-Fc map (contoured at 3.0 σ and colored in green) overlaid
with the loop region encompassing residues 156–160 as in theWTmodel (PDB id 1U2C).Maps have been calculated by using the T190Mmodel where
residues (156–163) have been omitted from the calculation.
doi:10.1371/journal.pone.0124277.g004
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by PISA for each residue in the respective crystallographic models goes from -0.01 kcal/mole (Thr
inWT) to 0.74 kcal/mole (Met in T190M), indicating a potentially perturbing effect of the methi-
onine on the surrounding water molecules.
Fig 5. Superimposition of theWT and T190Mmutant S6 domains. The models are represented as ribbons, with WT colored in pink-salmon and T190M
colored in blue; Met 190 is highlighted in green and depicted as a ball-and-stick model. The “flexible loop” C-term residues Gln163 (T190M) and Asn160 (WT
and T190M) are also depicted as ball-and-stick models (Asn160 residue is partially modeled in 1U2C). B1 and B5 β-strands are white labeled for clarity. The
superimposition of the two crystal structures emphasize the different conformations of the respective loops encompassing residues (157–163).
doi:10.1371/journal.pone.0124277.g005
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An analysis of the solvent structure in the crystallographic models shows that while several
waters surrounding residue 190 are conserved in both WT and T190M, some differences in
the solvent organization are actually evident (as shown in the four panels of Fig 6). Namely,
WAT304 (WT, PDB id: 1U2C) interacts with Thr190 OH inWT but it is absent in T190M
(Fig 6A and 6B). The lack of WAT304 in T190M is rather interesting, as this water molecule
bridges together the B1 and B5 β-strands by interacting with the backbone of residues Val188
(O) and His296 (O), and with the side chains of residues Thr190 (Oγ1) and His296 (Nδ1).
WAT304 acts as hydrogen bonds donor towards residues Val188 (O) and His296 (O) and as
hydrogen bonds acceptor from Thr190 (Oγ1) and His296 (Nδ1) (Fig 6A). Such hydrogen
bonds are not observed in T190M due to the lack of a bridging solvent molecule that would sta-
bilize the interaction between the B1 and B5 β-strands (Fig 6B). Moreover, solvent structure
changes were also found in a region occupied in T190M by Asn160, whereas the same space is
populated by solvent waters in WT (Fig 6B). Indeed, Asn160, which is part of the flexible loop
discussed above, protrudes from the loop towards Met190 acting, through Oδ1, as an acceptor
of bifurcated hydrogen bonds fromWAT660 andWAT638 water molecules (T190M, PDB id:
4QWI); Met190 in turn interacts, still through hydrogen bonds, with Oγ of Ser257, and with
other solvent molecules (Fig 6C). In the WT crystal structure WAT660 is not present and
WAT638 does not mediate any interaction between the flexible loop and Ser257 (Fig 6D).
It is quite apparent that the substitution of a hydrophilic residue such as threonine with a
bulkier and apolar one like methionine results in a solvent re-organization around the residue
itself. Changes in the structure solvation sphere may have significant consequences on the con-
formation of the (159–179) loop. Altogether, the loop relocation and the modified solvation
sphere may affect the protein stability and, eventually, also the mutual orientation of the two
domains in solution.
Stability measurements
Chemical unfolding experiments have been performed in order to establish the relative stabili-
ties of WT and T190M in solution. Fluorescence emission has been used as a mean to record
the exposure of the aromatic residues (mainly Trp) to the solvent, with emission maxima that
range from 310 nm of the fully buried to 350 nm of the fully exposed tryptophan residues
[33]. The four tryptophan residues in the WT primary sequence are good fluorescent probes
of the unfolding behavior of the domain and its mutant upon addition of a chemical denatur-
ant such as GdnHCl. Fig 7A shows the unfolding curves of WT and T190M as a function of
GdnHCl concentration. In the absence of denaturant, the emission spectra of both WT and
T190M are those of native-like proteins, with peaks in the spectral region of buried tryptophan
residues; the fact that the mutant’s peak is slightly red-shifted as compared to the wild-type
might reflect an increased exposure of one or more of its tryptophan residues to the solvent.
The plot of the emission spectra peaks as a function of GdnHCl reveals a cooperative unfolding
behaviour for both WT and T190M, with transition midpoints (Gdn50%, i.e. the denaturant
concentration inducing 50% of the total peak shift) of 1.45M and 1M, respectively, indicating
that WT is more stable than T190M.
To gain further insights into the stability of the two variants of the α-DG N-terminal do-
main, limited proteolysis experiments have been performed. Both variants contain 19 predicted
potential sites for trypsin cleavage (Peptide cutter tool at http://web.expasy.org) and therefore
are likely to be completely degraded following trypsin digestion. T190M was rapidly cleaved by
trypsin and completely degraded within 10 minutes of digestion (Fig 7B). WT instead was less
susceptible to tryptic cleavage and showed a clear degradation only after 40 minutes of diges-
tion (Fig 7B) but was still present after 1 hour of digestion. Considering that neither of the two
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Fig 6. Details of the hydrogen bond networks involving selected water molecules and residues. The structural elements of the N-terminal domain of α-
DG are represented as ribbon; residues involved in the interaction networks are represented as sticks. Interatomic distances are reported in Å. The color
scheme for WT and T190Mmodels is the same as in Fig 5. A) hydrogen bond network involvingWAT304, Thr190 and Val188 in WT, with the B1 and B5 β-
strands labeled for clarity. B) The T190Mmodel is shown in the same orientation asWT. Water molecules less than 8 Å apart from a putative WAT304 are
also shown. C) WT hydrogen bond network involving Ser257 and the “flexible loop”. Water molecules less than 8 Å apart from a putative WAT660 (water
numbering as in PDB id: 1U2C) are also shown. D) T190M hydrogen bond network involving Ser257, WAT660 andWAT638. The T190Mmodel is shown in
the same orientation asWT. The comparison of the mutated T190M with WT highlights the differences existing in their solvent structures and emphasizes
their role in the interplay between protein structural elements.
doi:10.1371/journal.pone.0124277.g006
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variants is subjected to degradation in the absence of the protease in the same experimental
conditions, T190M is clearly more susceptible to proteolysis than WT, confirming the latter to
be more stable, in accordance with the results of the chemical denaturation experiments.
Super Resolution Microscopy
The Osteoclast cell line U2OS has been transfected both with the EGFP plasmids carrying the
WT and T190M full-length DG variants [19], respectively and the cells have been analyzed by
3D structured illumination microscopy on an OMX v.4 system.
No relevant differences have been observed between WT and T190M, either following the
EGFP signal reporting β-DG localization (Fig 8A and 8B) or the anti-Myc reporting α-DG lo-
calization (Fig 8C). In both variants, DG undergoes its maturation cycle and it is extensively
Fig 7. Relative stabilities of WT and T190M. A. Equilibrium unfolding curves of WT and T190M. The red-
shifts in the fluorescence peaks upon addition of GdnHCl indicate a progressive exposure of the tryptophan
residues to the solvent: the data fit to a single cooperative transition for both WT, closed circles, and T190M,
open circles, with a difference in midpoints (Gdn50%) of 0.45M, that reveals the mutant to be less stable than
the wild-type protein. Both experiments were performed in triplicate, and no significant deviation from the
above curves was detected. B. Limited proteolysis of WT and T190M. The tryptic digestion time course of the
two variants is shown. The faint band(s) below the main band of full length T190M are likely to represent
some contaminants and/or the result of a minor degradation event taking place during the purification steps.
doi:10.1371/journal.pone.0124277.g007
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trafficked via the endoplasmic reticulum to the plasma membrane where it is nicely localized
to filopodia and also to podosomes located at the cell periphery. Notably, β-DG colocalizes
with the plasma membrane stain while the anti-Myc α-DG signal appears slightly shifted at the
outside of the cell, suggesting no dramatic alterations as far as the distribution of the two DG
subunits is concerned.
Discussion
According to the high resolution X-ray crystal structure here presented, the overall structure of
the N-terminal domain of α-DG is not significantly affected by the T190Mmutation, nor re-
markable local conformational changes of the residues close to position 190 have been de-
tected. At large, this finding seems to be fully supported by the fluorescence microscopy
analysis, which does not record dramatic differences in the phenotype of T190M transfected
osteoclasts with respect to their WT counterpart. The outcome of the fluorescence microscopy
experiments (showing that both DG subunits have a typical localization pattern in T190M) is
definitely indicating that the mutation is acting in quite a subtle and intriguing molecular regu-
latory fashion, or anyway that its effect would be much less observable in an isolated cellular
context than in skeletal muscle fibres [18].
The major effect of the T190Mmutation seems to be related to the disruption by the bulkier
and apolar methionine side chain of the surrounding solvent network structure. Indeed, it is
well known that solvation may play a critical role on the stability and the conformational equi-
librium of a macromolecule [34], as well as on the protein-ligands interactions [35]. Further-
more, it has been reported that even a single mutation at the surface of a protein, can
significantly affect the folding/unfolding free energies as a result of altering the solvent organi-
zation [36]. In T190M the differences observed in the solvent organization around Met190
may account for the structural and thermodynamic differences observed with respect to WT.
Indeed, T190M resolves in the formation of a new hydrogen bonding network involving
Asn160 and the water molecule WAT660, which may influence the flexibility of the 159–179
loop. Moreover, the loss of stabilizing interactions between the B1 and B5 β-strands due to the
absence of WTWAT304, may play a role in the T190M lower stability revealed by the chemical
denaturation and limited proteolysis experiments (see below).
Indeed, a particularly interesting aspect seems to be that in this case part of the flexible loop
encompassing residues 160–180 that in the WT domain was even less structured, due to its
high mobility and flexibility [13], assumes in T190M a different conformation. Such a result
leads to hypothesize that the Thr to Met mutation could have an impact on the structural dy-
namics of the entire N-terminal domain. The enhanced rigidity of T190Mmay affect the over-
all dynamics and orientation of the two subdomains within the L-shaped α-DG molecular
architecture, eventually influencing its global conformation and its function.
Fig 8. 3D Structured Illumination Microscopy images of U2OS cells expressing DG and DGT190M fused
to EGFP.DG-EGFP (A) and DGT190M-EGFP (B) are both localized specifically at the plasmamembrane and
accumulate in the cytoplasm. The columns show the individual images for DAPI (blue), EGFP (green),
Cellmask PlasmaMembrane Orange (red) and the resulting RGB overlay. The first row of images is the z
stack maximum intensity projection of the 3D recording of the cell. The two subsequent rows of images are at
a specific z position in the stack (XY) and X position slice through the stack (XZ). The white bar represents
10μm. Immunolabelling of Myc-tagged Dystroglycan (C) shows a specific signal at the plasmamembrane.
The individual maximum intensity z-stack projection images for the EGFP, Cellmask Orange and anti Myc
channels are shown as well as an overlay. Four by four μmmagnifications of the corresponding white dashed
boxes depict the Myc-tag signal at the outside of the plasmamembrane (filopodia). The antibody stain
appears nicely shifted toward the outside of the plasmamembrane, while GFP and Cellmask orange
are overlapping.
doi:10.1371/journal.pone.0124277.g008
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This possibility seems to be corroborated by the evidence that in solution T190M has a
lower stability than the WT, as suggested by the different melting points calculated on their un-
folding curves. Although the T190M denaturation curve has a melting point at about 1 M
GdnHCl, denoting a rather stable protein, the decrease in stability with respect to WT is small
but significant, as further confirmed by limited proteolysis experiments.
Potential consequences of T190M/T192M on the DG-LARGE
connection
The exact molecular mechanism leading to hypoglycosylation of α-DG carrying the T190M
(T192M in human) mutation and causing a severe dystrophic phenotype, accompanied by
some degree of intellectual impairment, is currently unknown [18]. Via co-immunoprecipita-
tion experiments, it was shown by Hara and colleagues that the mutated N-terminal domain of
α-DG is likely to exhibit a reduced affinity towards LARGE. This glycosyltransferase is respon-
sible for adding a repeating disaccharide unit [-α3-GlcA-β3-Xyl-], that is thought to be crucial
for extracellular matrix protein binding, to O-mannosylated α-DG [18]. Therefore, it is reason-
able to hypothesize that the degree of local perturbation and/or reduced stability measured in
T190M in solution could affect the conformation of the N-terminal domain of α-DG, influenc-
ing its binding to LARGE and provoking, at least in some cell types or tissues, a significant
hypoglycosylation of α-DG.
Kanagawa and colleagues have shown that the N-terminal domain of α-DG is shed by furin,
in a process that is likely to take place into the intracellular Golgi compartments in which the
final steps of the DG maturation process are completed [37]. An alternative chronological
order dictating the chaotic molecular events taking place in the Golgi could imply that such
furin-driven enzymatic step would even anticipate LARGE binding to α-DG. In which case, it
is reasonable to postulate that such an autonomous domain of α-DG [12] may represent not
only a recognition substrate but also an (allosteric?) activator for LARGE [38].
Interestingly, following the findings of a recent computational docking study, it was hypoth-
esized that the T190M/T192M mutation might affect directly the binding of α-DG to laminins
[39]. However, we believe that such a mechanism would be highly unlikely. Although we previ-
ously measured in the recombinant WT the presence of some residual binding activity towards
laminin-1 [13], the estimated affinity was lower than that observed for full-length and glycosy-
lated native α-DG binding to laminin and agrin [5,11,40]. In addition, such residual binding
activity was apparently harbored by the first Ig-like domain of α-DG and not by the S6-like do-
main where the T190M/T192M mutations resides [13]. α-DG post-translational O-glycans
decorations along the endoplasmic reticulum and modifications accomplished in the Golgi, are
crucial for its ability to function as an extracellular matrix (EM) receptor and namely to bind to
EM proteins such as laminin, perlecan, agrin and neurexin in the brain and pikachurin in the
retina [5]. Notably, the same are required for the binding of α-DG to Old World arenaviruses
[16]. Recently, a β-1,4-glucuronyltransferase, designated B4GAT1, has been also identified to
be involved in the initiation of the LARGE-dependent enzymatic process [41,42].
Although a few glycosylation sites have been proposed and/or localized within the N-termi-
nal and C-terminal domains of α-DG, most of the O-linked oligosaccharide chains protrude
from Thr and Ser residues placed within its central mucin-like domain [2,43,44]. A thorough
biophysical characterization of the “naked”mucin-like domain of α-DG clearly pointed to the
dramatic role played by the glycosylation in its conformational stability [45].
Unraveling the molecular mechanism of disease induced by T190M/T192M is likely to be
rather complex and additional hypothesis can be formulated. For example, the unveiled struc-
tural basis for the recognition of an O-glycan, GalNAc-Neu5Ac, and its attached mucin-like
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peptide GPATPAP by the paired Ig-like type 2 receptor α [46] suggests that the Ig-like domain
within the N-terminal α-DG region could function as a protein “hub” for the recognition of
the oligosaccharides protruding from the neighboring α-DG mucin-like domain. Furthermore,
the same domain could act as a direct docking site for one of the two domains of the glycosyl-
transferase LARGE [47], belonging to the GT-8 and GT-49 families respectively [48]. Indeed,
two mutations hitting the N-terminal Ig-like domain have been recently reported in a patient
with hypoglycosylated α-DG [49].
Possibly, in solution, the effect of the T190Mmutation, which is next to the flexible hinge
connecting the two subdomains, may “propagate” to the Ig-like domain by changing its relative
orientation with respect to the S6-like domain also influencing its binding properties. It is wor-
thy of note that the presence of a second Ig-like domain within the C-terminal region of α-DG
has been confirmed by bioinformatics analysis and molecular modeling; the domain has been
biochemically characterized and shown to include the β-DG binding epitope [50].
Conclusions
Such interesting structural hypotheses necessarily await further rounds of experimental/
computational validations by means of techniques being able to explore the dynamical behav-
ior of α-DG (NMR, Molecular Dynamics). Furthermore, molecular modeling and docking
tools will be exploited to investigate the likelihood of α-DG binding to LARGE or to other reg-
ulatory factors important for DG maturation. The present structural analysis of the N-terminal
T190M variant of α-DG may pave the road to the elucidation of the molecular mechanism of a
specific case of dystroglycanopathy, with important consequences for clinicians and for design-
ing possible therapies, but in addition it may be also relevant from a cellular and molecular bi-
ology perspective, helping to improve the overall picture of the multiple structural aspects
underlying the maturation and function of the DG complex.
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